Tevogen Bio Holdings Inc. (NASDAQ:tvgn)
Industry: Biotechnology

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Current Quote*
Last: $10.750
Change: -2.000
Book: $Unk
Volume: 21,479

As Of: 06/12 16:04 ET
*Quotes delayed by 20min.

Graphs for TVGN


3 Month Graph


6 Month Graph


1 Year Graph